MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by neuropsychological symptoms such as anxiety, depression and progressive cognitive deficits along with the deposition of extracellular plaques composed of β-amyloid (Aβ) and intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein.